Product References
Phase II Trial of Target-guided Personalized Chemotherapy in First-line Metastatic Colorectal Cancer.
American journal of clinical oncology
Cubillo A,Rodriguez-Pascual J,López-Ríos F,Plaza C,García E,Álvarez R,de Vicente E,Quijano Y,Hernando O,Rubio C,Perea S,Sanchez G,Hidalgo M
MA1-46059 was used in immunohistochemistry to perform a phase II clinical trial in patients with advanced metastatic colorectal cancer to study the feasibility of a targeted personalized chemotherapy approach
Wed Jun 01 00:00:00 EDT 2016
Impact of intratumoral expression levels of fluoropyrimidine-metabolizing enzymes on treatment outcomes of adjuvant S-1 therapy in gastric cancer.
PloS one
Kim JY,Shin E,Kim JW,Lee HS,Lee DW,Kim SH,Lee JO,Kim YJ,Kim JH,Bang SM,Ahn SH,Park DJ,Lee JS,Lee JS,Kim HH,Lee KW
MA1-46059 was used in immunohistochemistry - paraffin section to identify biomarkers relevant to treatment outcomes in gastric cancer patients receiving adjuvant S-1 chemotherapy.
Tue Feb 09 00:00:00 EST 2016
A prospective pilot study of target-guided personalized chemotherapy with intensity-modulated radiotherapy in patients with early rectal cancer.
American journal of clinical oncology
Cubillo A,Hernando-Requejo O,García-García E,Rodriguez-Pascual J,De Vicente E,Morelli P,Rubio C,López-Ríos F,Muro A,López U,Prados S,Quijano Y,Hidalgo M
MA1-46059 was used in immunohistochemistry to study whether personalized neoadjuvant chemotherapy is feasible in patients with early-stage rectal cancer
Tue Apr 01 00:00:00 EDT 2014
A phase II study of combination chemotherapy with capecitabine and cisplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck.
Annals of oncology : official journal of the European Society for Medical Oncology
Won YW,Park YH,Ahn MJ,Do IG,Ko YH,Park K
MA1-46059 was used in immunohistochemistry to study the efficacy and toxicity of combination chemotherapy in head and neck cancer.
Tue Feb 01 00:00:00 EST 2011
Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts.
Disease markers
Starlinger P,Alidzanovic L,Schauer D,Brugger P,Sommerfeldt S,Kuehrer I,Schoppmann SF,Gnant M,Brostjan C
MA1-46059 was used in ELISA to discuss technical factors that influence the analysis of angiogenesis factors in the blood of tumor patients
Thu Dec 22 00:00:00 EST 2011
Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.
Cancer chemotherapy and pharmacology
Lee SJ,Choi YL,Park YH,Kim ST,Cho EY,Ahn JS,Im YH
MA146059 was used in immunohistochemistry - paraffin section to assess the use of thymidylate synthase and thymidine phosphorylase as biomarkers to predict clinical outcomes of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer
Thu Sep 01 00:00:00 EDT 2011
Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma.
British journal of cancer
Lee S,Park YH,Kim KH,Cho EY,Ahn YC,Kim K,Shim YM,Ahn JS,Park K,Im YH
MA1-46059 was used in immunohistochemistry to study biomarkers for predicting the response to capecitabine and cisplatin combination chemotherapy in metastatic oesophageal squamous cell cancer
Tue Sep 07 00:00:00 EDT 2010
Epstein-Barr virus latent membrane protein 1 induces the chemotherapeutic target, thymidine phosphorylase, via NF-kappaB and p38 MAPK pathways.
Cellular signalling
Chen CC,Chen LC,Liang Y,Tsang NM,Chang YS
MA1-46059 was used in immunohistochemistry to investigate the mechanism for the induction of thymidine phosphorylase by Epstein-Barr virus latent membrane protein 1
Thu Jul 01 00:00:00 EDT 2010
Combination chemotherapy with S-1 and platinum in advanced hepatocellular carcinoma.
Anticancer research
Kim SJ,Han SW,Oh DY,Yi NJ,Kim YJ,Im SA,Yoon JH,Kang GH,Suh KS,Bang YJ,Jang JJ,Kim TY
MA1-46059 was used in immunohistochemistry to study combination chemotherapy with S-1 and platinum in advanced hepatocellular carcinoma.
Wed Dec 01 00:00:00 EST 2010
Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study.
European journal of cancer (Oxford, England : 1990)
Koopman M,Venderbosch S,van Tinteren H,Ligtenberg MJ,Nagtegaal I,Van Krieken JH,Punt CJ
MA1-46059 was used in immunohistochemistry to identify the prognostic markers for advanced colorectal cancer chemotherapy
Wed Jul 01 00:00:00 EDT 2009
Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer.
British journal of cancer
Han SW,Oh DY,Im SA,Park SR,Lee KW,Song HS,Lee NS,Lee KH,Choi IS,Lee MH,Kim MA,Kim WH,Bang YJ,Kim TY
MA1-46059 was used in immunohistochemistry to study the efficacy of combined cetuximab and modified FOLFOX6 treatment in a phase II gastric cancer trial
Tue Jan 27 00:00:00 EST 2009
Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
Brockenbrough JS,Morihara JK,Hawes SE,Stern JE,Rasey JS,Wiens LW,Feng Q,Vesselle H
MA1-46059 was used in immunohistochemistry to investigate the expression level and role of thymidine kinase 1 and thymidine phosphorylase in non-small-cell lung carcinoma
Sun Nov 01 00:00:00 EDT 2009
Anti-tumor effect of cimetidine via inhibiting angiogenesis factors in N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse and rat bladder carcinogenesis.
Oncology reports
Chihara Y,Fujimoto K,Miyake M,Hiasa Y,Hirao Y
MA146059 was used in immunohistochemistry - paraffin section to evaluate the anti-tumor effect and mechanisms of cimetidine using a N-butyl-N-(4-hydroxybutyl) nitrosamine-induced model of bladder cancer
Wed Jul 01 00:00:00 EDT 2009
Neoadjuvant treatment of colorectal cancer with bevacizumab: the perioperative angiogenic balance is sensitive to systemic thrombospondin-1 levels.
Clinical cancer research : an official journal of the American Association for Cancer Research
Brostjan C,Gebhardt K,Gruenberger B,Steinrueck V,Zommer H,Freudenthaler H,Roka S,Gruenberger T
MA1-46059 was used in ELISA to investigate the systemic angiogenic status in patients with colorectal cancer undergoing bevacizumab therapy
Tue Apr 01 00:00:00 EDT 2008
Neoadjuvant docetaxel and capecitabine in patients with high risk prostate cancer.
The Journal of urology
Friedman J,Dunn RL,Wood D,Vaishampayan U,Wu A,Bradley D,Montie J,Sarkar FH,Shah RB,Hussain M
MA1-46059 was used in immunohistochemistry to investigate the association between neoadjuvants docetaxel and capecitabine and prostate cancer
Sat Mar 01 00:00:00 EST 2008
A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma.
Cancer chemotherapy and pharmacology
Lee J,Im YH,Cho EY,Hong YS,Lee HR,Kim HS,Kim MJ,Kim K,Kang WK,Park K,Shim YM
MA1-46059 was used in immunohistochemistry to perform a phase II study of capecitabine and cisplatin chemotherapy in patients with advanced esophageal squamous cell carcinoma
Sun Jun 01 00:00:00 EDT 2008
A possible role of thymidine phosphorylase expression and 5-fluorouracil increased sensitivity in oropharyngeal cancer patients.
Journal of cellular and molecular medicine
Ranieri G,Grammatica L,Patruno R,Zito AF,Valerio P,Iacobellis S,Gadaleta C,Gasparini G,Ribatti D
MA1-46059 was used in immunohistochemistry to study the role of thymidine phosphorylase expression in increased sensitivity to 5-fluorouracil in oropharyngeal cancer patients
Tue Jul 17 00:00:00 EDT 2007
H pylori status and angiogenesis factors in human gastric carcinoma.
World journal of gastroenterology
Mangia A,Chiriatti A,Ranieri G,Abbate I,Coviello M,Simone G,Zito FA,Montemurro S,Rucci A,Di Leo A,Tommasi S,Berloco P,Xu JM,Paradiso A
MA1-46059 was used in immunohistochemistry to study Helicobacter pylori antigen and angiogenesis factors in human gastric carcinoma
Thu Sep 14 00:00:00 EDT 2006
Upregulation of thymidine phosphorylase in chronic glomerulonephritis and its role in tubulointerstitial injury.
Nephron. Clinical practice
Wang EH,Goh YB,Moon IS,Park CH,Lee KH,Kang SH,Kang CS,Choi YJ
MA1-46059 was used in immunohistochemistry to study the upregulation of thymidine phosphorylase in chronic glomerulonephritis
Thu Jul 13 00:00:00 EDT 2006
Prognostic significance of thymidine phosphorylase in superficial bladder carcinoma.
International urology and nephrology
Stavropoulos NE,Bouropoulos C,Ioachim E,Michael M,Hastazeris K,Tsimaris I,Kalogeras D,Liamis Z,Kafarakis V,Stefanaki S,Malamou-Mitsi V
MA1-46059 was used in immunohistochemistry to study the prognostic value of thymidine phosphorylase in superficial bladder carcinoma
Tue Sep 19 00:00:00 EDT 2006
Monitoring of circulating angiogenic factors in dendritic cell-based cancer immunotherapy.
Cancer
Brostjan C,Bayer A,Zommer A,Gornikiewicz A,Roka S,Benkö T,Yaghubian R,Jakesz R,Steger G,Gnant M,Friedl J,Stift A
MA1-46059 was used in ELISA to investigate the importance of circulating angiogenic factors in dendritic cell-based cancer immunotherapy
Sat Nov 15 00:00:00 EST 2003
Angiogenic growth factors in preinvasive breast disease.
Clinical cancer research : an official journal of the American Association for Cancer Research
Heffelfinger SC,Miller MA,Yassin R,Gear R
MA1-46059 was used in immunohistochemistry to investigate the mechanism for the increased vascularity in preinvasive breast disease
Fri Oct 01 00:00:00 EDT 1999
